FLORENCE PUGH: Open Payments
NPI 1780188128 · LIVE OAK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 32 payments from 12 companies in 2025. Trend: 2023 $814 · 2024 $1,040 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $200 |
| Novo Nordisk Inc | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| PFIZER INC. | 3 | $45 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Exact Sciences Corporation | 2 | $28 |
| Lilly USA, LLC | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: VRAYLAR, Wegovy, QULIPTA, NURTEC ODT, Symbravo, AIRSUPRA, UBRELVY, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
